Researchers find promise in new treatments for GBM
2014-10-01
(Press-News.org) (Boston) — Glioblastma multiforme (GBM) is one of the most lethal primary brain tumors, with median survival for these patients only slightly over one year. Researchers at Boston University School of Medicine (BUSM), in collaboration with researchers from the City of Hope, are looking toward novel therapeutic strategies for the treatment of GBM in the form of targeted therapies against a unique receptor, the interleukin-13 receptor α chain variant 2 (IL13Rα2).
In a review paper published in the October issue of Neuro-Oncology, the researchers discuss various targeted therapies against IL13Rα2 and early successes of clinical trials with these therapies in the treatment of GBM. The paper also highlights the need for future trials to improve efficacy and toxicity profiles of targeted therapies in this field.
Targeted therapies, which are drugs that interfere with specific molecules involved in cancer growth, have been successfully used in the treatment of many cancers, including breast and blood cancers. Successful targets for therapies are specific to tumor cells and not found on normal cells. Selectively expressed on GBM and absent on surrounding brain tissue, the interleukin-13 receptor α chain variant 2 (IL13Rα2) was identified as a potential target for therapy for GBM two decades ago. IL13Rα2 also plays an important role in the growth of tumors. In normal physiologic conditions, IL-13 binds to the receptor IL13Rα1 and helps regulate immune responses. In cancer cells, IL-13 binds to the receptor IL13Rα2 and, through a series of steps, prevents cancer cells from undergoing normal cell death. Increased expression of IL13Rα2 promotes the progression of GBM.
Since its discovery, IL13Rα2 has provided a target for therapies in GBM. These therapies have ranged from fusion proteins of IL-13 and bacterial toxins, oncolytic viruses, and immunotherapies. A phase I clinical trial and a phase III clinical trial have been completed for a T-cell based immunotherapy and IL-13 bacterial toxin fusion protein respectively, both with promising outcomes.
"The field of targeted therapies in gliomas holds a lot of promise, and IL13Rα2 is in an optimal position to materialize these promises," explained corresponding author Sadhak Sengupta, PhD, assistant professor of neurosurgery at BUSM and principal investigator of the Brain Tumor Lab at Roger Williams. "While early trials are encouraging, we need further research to achieve better targeting of the receptor and improved safety profiles of the treatments."
INFORMATION:
Funding for this research was provided by the Roger Williams Medical Center Brain Tumor Research Fund.
ELSE PRESS RELEASES FROM THIS DATE:
2014-10-01
An international research team's field work, drilling and measuring melt rates and ice sheet movement in Greenland is showing that things are, in fact, more complicated than we thought.
"Although the Greenland Ice Sheet initially speeds up each summer in its slow-motion race to the sea, the network of meltwater channels beneath the sheet is not necessarily forming the slushy racetrack that had been previously considered," said Matthew Hoffman, a Los Alamos National Laboratory scientist on the project.
A high-profile paper appearing in Nature this week notes that observations ...
2014-10-01
VIDEO:
NASA's TRMM satellite saw Phanfone was producing rainfall over a very large area on Oct. 1. Some storms in these bands were dropping rain at a rate of over 76...
Click here for more information.
An intensifying typhoon called Phanfone that originated east of Guam on September 28, 2014 is headed toward southern Japan. The TRMM satellite crossed above Typhoon Phanfone on October 1, 2014 at 1039 UTC and gathered data about rainfall rates occurring in the storm.
TRMM, ...
2014-10-01
The monarch butterfly is one of the most iconic insects in the world, best known for its distinct orange and black wings and a spectacular annual mass migration across North America. However, little has been known about the genes that underlie these famous traits, even as the insect's storied migration appears to be in peril.
Sequencing the genomes of monarch butterflies from around the world, a team of scientists has now made surprising new insights into the monarch's genetics. They identified a single gene that appears central to migration – a behavior generally regarded ...
2014-10-01
To protect their gut microbes during illness, sick mice produce specialized sugars in the gut that feed their microbiota and maintain a healthy microbial balance. This protective mechanism also appears to help resist or tolerate additional harmful pathogens, and its disruption may play a role in human diseases such as Crohn's disease, report scientists from the University of Chicago in Nature on Oct 1.
"Both hosts and their gut microbiota can suffer in the case of sickness, but this mutually beneficial relationship is guarded by the host," said study senior author Alexander ...
2014-10-01
Chemicals released into the air by oil and gas exploration, extraction and related activities can spark reactions that lead to high levels of ozone in wintertime, high enough to exceed federal health standards, according to new NOAA-led research, published today in Nature.
The study comes at a time when new technologies are helping to accelerate oil and gas development in Utah's Uintah Basin, elsewhere in the United States and in many other countries, and its findings may help air quality managers determine how to best minimize the impact of ozone pollution.
When ozone ...
2014-10-01
AUSTIN, Texas—A team led by scientists at the University of Texas at Austin's Institute for Geophysics has for the first time directly observed multiple parts of Greenland's subglacial plumbing system and how that system evolves each summer to slow down the ice sheet's movement toward the sea.
These new observations could be important in accurately modeling Greenland's future response to climate change.
"Everyone wants to know what's happening under Greenland as it experiences more and more melt," said study coauthor Ginny Catania, a research scientist at the institute ...
2014-10-01
Titan is unique in our solar system because of its dense nitrogen-methane atmosphere, which is very similar to Earth's in some ways, but very different in others. For example, air temperatures are around 200 degrees colder and, in contrast to the warm salt water seas of Earth, frigid hydrocarbon lakes populate Titan's surface.
Titan has seasons just like Earth, only each season lasts over seven years instead of three months due to its ponderous orbit around the Sun. After equinox in 2009, Titan's south pole entered the perpetual darkness of polar winter. Soon after, ...
2014-10-01
New data obtained by NASA's GRAIL mission reveals that the Procellarum region on the near side of the moon — a giant basin often referred to as the "man in the moon" — likely arose not from a massive asteroid strike, but from a large plume of magma deep within the moon's interior.
The Procellarum region is a roughly circular, volcanic terrain some 1,800 miles in diameter — nearly as wide as the United States. One hypothesis suggested that it was formed by a massive impact, in which case it would have been the largest impact basin on the moon. Subsequent asteroid collisions ...
2014-10-01
PROVIDENCE, R.I. [Brown University] — Oceanus Procellarum, a vast dark patch visible on the western edge of the Moon's near side, has long been a source of mystery for planetary scientists. Some have suggested that the "ocean of storms" is part of a giant basin formed by an asteroid impact early in the Moon's history. But new research published today in Nature deals a pretty big blow to the impact theory.
The new study, based on data from NASA's GRAIL mission, found a series of linear gravitational anomalies forming a giant rectangle, nearly 1,600 miles across, running ...
2014-10-01
CINCINNATI – Researchers developed a new type of cell transplantation to treat mice mimicking a rare lung disease that one day could be used to treat this and other human lung diseases caused by dysfunctional immune cells.
Scientists at Cincinnati Children's Hospital Medical Center report their findings in a study posted online Oct. 1 by Nature. In the study, the authors used macrophages, a type of immune cell that helps collect and remove used molecules and cell debris from the body.
They transplanted either normal or gene-corrected macrophages into the respiratory ...
LAST 30 PRESS RELEASES:
[Press-News.org] Researchers find promise in new treatments for GBM
